RealFeedApp beta

Do not view mTOR as a single pharmaceutical target

The study found that blocking PD-L1 in the brain restores glial cell function. Researchers advise not viewing mTOR as a single pharmaceutical target because context matters.

Field
ageing and longevity
What they did
Researchers demonstrated that blocking the protein PD-L1 in the brain restores the function of glial cells.
Why it matters
This could help in understanding aging mechanisms and developing treatments for age-related diseases.
#pd-l1#glial cells#mtor#aging

Read the original →